Peter Calabresi, MD
Enriched profileChair and Professor, Department of Neurological Sciences · Larner College of Medicine
Peter Calabresi is Chair and Professor, Department of Neurological Sciences at Larner College of Medicine. OpenAlex indexes 910 publications with 61,106 citations (h-index 113); ClinicalTrials.gov lists 4 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 1% of Neurology profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 14 Oct 2026
Peter Calabresi, MD, is Chair and Professor, Department of Neurological Sciences at Larner College of Medicine, University of Vermont. The public record shows 910 publications with 61,106 citations (h-index 113), centered on Multiple Sclerosis. It also documents an investigator role on 4 registered clinical trials, industry payments reported by 6 companies.
- Most recent indexed publication: 2026 · Neurology
- Top research focus: Multiple Sclerosis
- 4 registered trials on ClinicalTrials.gov
- Open Payments reporting from 6 companies
Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 103 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Public positions
sourced statements on record- Standing member
NIH Clinical Neuroimmunology and Brain Tumors Study Section (per CV listing; page did not render for direct confirmation)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →uvm.edu ↗
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 14 Oct 2026
Listed as an investigator on 4 registered studies on ClinicalTrials.gov. The most recent:
- Trial of eHealth Wellness Behavioral Interventions and Patient-reported Outcomes
Sponsor: Johns Hopkins University
- Safety and Immunologic Effect of Low Dose Versus High Dose Vitamin D3 in Multiple Sclerosis
Sponsor: Johns Hopkins University
Industry payments
Updated 14 Oct 2026
6 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- ROCHE DIAGNOSTICS INTERNATIONAL LTDProgram year20255 payments
- Biogen, Inc.Program year20252 payments
- Novartis Pharmaceuticals CorporationProgram year20256 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
63.2%Gabapentinoids15.9%Gabapentin100%Part D<11 patientsPotassium Channel Blocker13.9%Dalfampridine Er100%Part D<11 patients+ 5 more classes in this area
Musculoskeletal
28.9%gamma-Aminobutyric Acid-ergic Agonist23.4%Baclofen100%Part D≥11 patientsCentral alpha-2 Adrenergic Agonist5.5%Tizanidine Hcl100%Part D<11 patientsCancer & immunology
8%Other immunostimulants8%Glatopa100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
Updated 14 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Challenges and future directions for multiple sclerosis after the 2024 McDonald diagnostic criteria.
Nature medicine
Article2026 - Association of epiretinal membranes with disability in people with multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England)
Article2026 - Oligodendrocyte Piezo2 is a regulator of age-dependent myelin integrity and dysregulated in multiple sclerosis.
Communications biology
Article2026 - The exercise hormone irisin has neuroprotective effects in a mouse model of multiple sclerosis.
Nature metabolism
Article2026
Online presence
Updated 14 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/peter-calabresi-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- Instagram
instagram.com/p/DMvm5LIvZ6R
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →instagram.com ↗ - Other
realtalkms.com/bonus-an-actrims-forum-conversation-with-dr-peter-calabresi
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →realtalkms.com ↗ - Other
realtalkms.com/ectrims-extra-revisions-to-the-way-ms-is-diagnosed-with-dr-peter-calabresi
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →realtalkms.com ↗ - X / Twitter
x.com/uvmvermont/status/1981058730289480128
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 14 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- Residency
Internal Medicine and Neurology, Strong Memorial Hospital, University of Rochester (served as chief resident)
- Fellowship
Neuroimmunology, NINDS/National Institutes of Health
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usnews.com ↗
- Fellow
American College of Physicians (FACP)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →2020.myana.org ↗
Editorial & leadership roles
journal and society appointments- Former Director
Richard T. Johnson Division of Neuroimmunology and Neurological Infections, Johns Hopkins School of Medicine
2025 - Editorial Board member
Journal of Clinical Investigation
- Editorial Board member
Neurology
- Editorial Board member
Multiple Sclerosis Journal
Awards & honors
honors on the public record- Elected to the National Academy of Medicine (2025)
cited for international leadership in MS pathogenesis, therapies, and OCT-based retinal neurodegeneration research
2025 - Giants in Multiple Sclerosis Research Award
Consortium of Multiple Sclerosis Centers
- Stephen C. Reingold Research Award
National Multiple Sclerosis Society
- Raymond D. Adams Lectureship
American Neurological Association
Secondary affiliations
appointments beyond the home institution- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →neurologylive.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →neurologylive.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →realtalkms.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Bruce Miller, MD
University of California, San Francisco (UCSF)
Bradley Boeve, MD
Mayo Clinic
Richard Lipton, MD
Albert Einstein College of Medicine
Steven Dekosky, MD
University of Florida